Budesonide Capsule, Delayed Release
Product Images NDC 65162-778

2 FDA label images from Amneal Pharmaceuticals Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Budesonide (NDC 65162-778). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Budesonide Delayed Release Capsules 1)

Structural Formula (Budesonide Delayed Release Capsules 1)
Chemical structure diagrams of two epimers of budesonide, labeled as Epimer 22R and Epimer 22S, showing the molecular configuration variations in the compound.*
FDA Label Image

Ju (Budesonide Delayed Release Capsules 2)

Ju (Budesonide Delayed Release Capsules 2)
Label for Budesonide Delayed-Release Capsules 3 mg by Amneal Pharmaceuticals LLC. The label indicates 300 capsules per container and provides storage instructions, dosage information, and a barcode. The capsules are for oral use and prescription only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.